USANA Health Sciences, Inc. (USNA) Stock Price & Analysis

USANA Health Sciences, Inc. Company Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc.

USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products. The company operates primarily through direct sales in the Asia Pacific, the Americas, and Europe.

Key Facts

• Sector: Consumer Defensive
• Industry: Packaged Foods
• Headquarters: Salt Lake City, UT, US
• CEO: Kevin G. Guest
• Employees: 1700

What USANA Health Sciences, Inc. Does

Develops and manufactures science-based nutritional supplements.,Offers a range of vitamin and mineral supplements for various age groups.,Provides targeted supplements for cardiovascular, skeletal, and digestive health.,Produces meal replacement shakes, snack bars, and related food products.,Offers Celavive, a skin care regimen for different skin types and ethnicities.,Provides products for prenatal, infant, and young child age groups.,Offers materials and online tools to assist associates in building their businesses.,Markets products directly in the Asia Pacific, the Americas, and Europe, as well as online.

Business Model

Direct sales through a network of independent distributors.,Manufacturing and selling nutritional and personal care products.,Online sales through the company's website.,Research and development of new products.

Key Competitors

Herbalife Nutrition, Nu Skin Enterprises

USNA Investment Analysis

Investment Thesis

USANA Health Sciences, Inc. presents a mixed investment thesis. The company's high gross margin of 76.7% indicates strong pricing power and efficient production. However, a low profit margin of 1.0% raises concerns about operational efficiency and cost management. The company's direct sales model offers growth potential in emerging markets, particularly in the Asia Pacific region. Key catalysts include expanding product lines and strategic partnerships. Potential risks include regulatory scrutiny, competition from established players, and reliance on its direct sales network. Investors should closely monitor sales growth, profitability trends, and regulatory developments.

Growth Catalysts

• Upcoming: Launch of new personalized nutrition products in Q3 2026, targeting a growing segment of health-conscious consumers.
• Ongoing: Expansion of the direct sales network in key Asian markets, driving revenue growth and market share.
• Ongoing: Continued investment in research and development to support product innovation and differentiation.
• Upcoming: Potential strategic partnerships with healthcare providers to expand distribution channels by Q4 2026.

Risk Factors

• Potential: Regulatory scrutiny of the direct sales model and product claims could impact operations.
• Potential: Fluctuations in raw material costs and supply chain disruptions could affect profitability.
• Ongoing: Intense competition from established players and new entrants in the nutritional supplement market.
• Ongoing: Changes in consumer preferences and dietary trends could impact product demand.

Analyst Coverage for USNA

USNA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our multi-factor AI model evaluates USNA against Consumer Defensive peers and assigns a mixed fundamental profile based on the underlying data. Peer-relative metrics and sector momentum carry more weight for USNA until institutional coverage emerges.

Questions & Answers

Is USNA a good stock to buy?

Whether USNA is a suitable investment depends on your goals, risk tolerance, and time horizon. Evaluate USANA Health Sciences, Inc.'s revenue growth, profit margins, debt levels, and valuation relative to peers. This is not financial advice—consult a qualified advisor before investing.

What is the USNA MoonshotScore?

The MoonshotScore rates USNA from 0 to 100 across growth potential, financial health, market momentum, and risk factors. It is updated as market data refreshes. This score is informational only—not a buy or sell recommendation.

How often is USNA data updated?

USNA's price is the last quote we recorded, from the Oct 5, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update as market data refreshes.

What are the risks of investing in USNA?

Risk categories for USNA include market risk, company-specific risk, financial risk (debt, cash burn), and macroeconomic risk. Review the Risk Factors section for details specific to this stock. All investments carry risk of loss.